
Omoye ES 40mg Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Esomeprazole (40mg)
Overview Omoye ES 40mg Tablet
Gastric acid-related conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome benefit from treatment with the 40mg Omoye ES Tablet. This medication diminishes stomach acid production, alleviating symptoms and fostering healing. It also safeguards against ulcers triggered by NSAIDs. Dosage, determined by your physician, should be the minimal effective amount for the shortest necessary duration, typically taken on an empty stomach, ideally in the morning or an hour before meals. Continue treatment as directed, even after symptom resolution. Long-term use might necessitate regular magnesium level monitoring due to potential depletion. Common, usually mild, side effects include headache, altered bowel habits (constipation or diarrhea), abdominal discomfort, and nausea or vomiting; report persistent or bothersome effects to your doctor. Prolonged use increases side effect risk, including potential for bone fractures. Dietary modifications, such as limiting rich, spicy, fatty foods, caffeine, and alcohol, are advisable. Consult your physician before use if you have severe hepatic impairment, take HIV medications, have prior allergic reactions to similar drugs, or suffer from osteoporosis. While alcohol doesn't directly affect the medication's mechanism, its acid-stimulating effect is counterproductive. Drowsiness, dizziness, or visual disturbances warrant avoidance of driving, cycling, or operating machinery. Use during pregnancy and breastfeeding is generally discouraged.
Uses of Omoye ES 40mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Omoye ES 40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Omoye ES 40mg Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking. Administer on an empty stomach.
Common Side effects of Omoye ES 40mg Tablet:
- Headache
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
How to use Omoye ES 40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Omoye ES 40mg Tablets. Ingest each tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
How Omoye ES 40mg Tablet works:
Each Omoye ES 40mg tablet contains a proton pump inhibitor that lessens stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Omoye ES 40mg Tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The effects of Omoye ES 40mg Tablet during pregnancy are unknown. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on Omoye ES 40mg Tablet use while breastfeeding is lacking. A physician's advice is recommended. Breastfeeding mothers should use Omoye ES 40mg Tablet with care.
DrivingUNSAFE
Taking Omoye ES 40mg Tablets may impair driving ability. Rarely, dizziness or blurred vision can occur; refrain from operating vehicles or machinery if these symptoms develop.
KidneySAFE IF PRESCRIBED
Omoye ES 40mg tablets are considered safe for use in individuals with kidney disease, and no dosage modification is advised. Nevertheless, a cautious approach is recommended for patients exhibiting severe renal impairment due to insufficient supporting data.
LiverCAUTION
For individuals with severe hepatic impairment, Omoye ES 40mg Tablets necessitate careful administration and potential dosage modification. Mild to moderate liver dysfunction, however, does not require dosage alteration. Physician consultation is advised.
What if you forget to take Omoye ES 40mg Tablet :
Should you forget to take your Omoye ES 40mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Omoye ES 40mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
